Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in DENALI THERAPEUTICS INC
CAPITAL FUND MANAGEMENT S.A. previously held 0 shares of DNLI (DENALI THERAPEUTICS INC), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$305,975
Total Shares Change
-21,871
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $14.52 |
0 |
| 2025-Q2 | New | 21,871 | - | $305,975 | 0.0% | $14.10 | 32 |